Movatterモバイル変換


[0]ホーム

URL:


Skip to main content
Springer Nature Link
Log in

Why Does Vomiting Stop a Migraine Attack?

  • Migraine (R Cowan, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

AnErratum to this article was published on 17 September 2013

Abstract

Migraine is commonly associated with nausea and vomiting, though, interestingly, vomiting has also been reported by some patients to be therapeutic, and may actually stop a migraine attack. In this review, we will first discuss the epidemiology of nausea and vomiting in migraine. Further, we will briefly review the connections between the enteric nervous system, the autonomic nervous system, and the central nervous system as they pertain to understanding the question of “Why does vomiting stop a migraine attack?”

This is a preview of subscription content,log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004;24 (Suppl.):S24–101.

  2. Martins IP, Parreira E. Behavioral response to headache: a comparison between migraine and tension-type headache. Headache. 2001;41:546–53.

    Article PubMed CAS  Google Scholar 

  3. Bag B, Karabulut N. Pain-relieving factors in migraine and tension-type headache. Int J Clin Pract. 2005;59:760–3.

    Article PubMed CAS  Google Scholar 

  4. Young WB, Silberstein SD. Migraine and other headaches. New York: AAN Press, Demos Medical Publishing; 2004.

    Google Scholar 

  5. Pearce JM. Historical aspects of migraine. J Neurol Neurosurg Psychiatry. 1986;49:1097–103.

    Article PubMed CAS  Google Scholar 

  6. Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry. 1960;23:23–32.

    Article PubMed CAS  Google Scholar 

  7. Lance JW, Anthony M. Some clinical aspects of migraine. A prospective survey of 500 patients. Arch Neurol. 1966;15:356–61.

    Article PubMed CAS  Google Scholar 

  8. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache. 1995;35:387–96.

    Article PubMed CAS  Google Scholar 

  9. • Lipton RB, Buse DC, Saiers J, et al. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2012;53:93–103.Persons with high-frequency nausea were found to bear higher burden of migraine, associated with being occupationally disabled and having more financial burden.

    Article PubMed  Google Scholar 

  10. Gupta R, Bhatia MS. A report of cranial autonomic symptoms in migraineurs. Cephalalgia. 2007;27:22–8.

    Article PubMed CAS  Google Scholar 

  11. Eidlitz-Markus T, Gorali O, Haimi-Cohen Y, et al. Symptoms of migraine in the paediatric population by age group. Cephalalgia. 2008;28:1259–63.

    Article PubMed CAS  Google Scholar 

  12. Gershon MD, Chalazonitis A, Rothman TP. From neural crest to bowel: development of the enteric nervous system. J Neurobiol. 1993;24:199–214.

    Article PubMed CAS  Google Scholar 

  13. Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453–66.

    Article PubMed CAS  Google Scholar 

  14. Gulbransen BD, Sharkey KA. Novel functional roles for enteric glia in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2012;9:625–32.

    Article PubMed CAS  Google Scholar 

  15. Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology. 2007;69:1953–7.

    Article PubMed  Google Scholar 

  16. Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261–74.

    Article PubMed CAS  Google Scholar 

  17. Becker DE. Nausea, vomiting, and hiccups: a review of mechanism and treatment. Anesthesia Progress. 2010;57:150–6.

    Article PubMed  Google Scholar 

  18. Sanger GJ, Andrews PL. Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci. 2006;129:3–16.

    Article PubMed CAS  Google Scholar 

  19. Andrews PL, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125:100–15.

    Article PubMed  Google Scholar 

  20. • Napadow V, Sheehan JD, Kim J, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex. 2013;23:806–13.Nausea evoked by visual stimuli is mapped with functional magnetic resonance imaging.

    Article PubMed  Google Scholar 

  21. Shapiro RE, Miselis RR. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol. 1985;238:473–88.

    Article PubMed CAS  Google Scholar 

  22. Travagli RA, Hermann GE, Browning KN, et al. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006;68:279–305.

    Article PubMed CAS  Google Scholar 

  23. Hornby PJ. Receptors and transmission in the brain-gut axis. II Excitatory amino acid receptors in the brain-gut axis Am J Physiol Gastrointest Liver Physiol. 2001;280:G1055–60.

    CAS  Google Scholar 

  24. Guyton AC, Hall JE. Textbook of medical physiology. 11th ed. Philadelphia, PA: Elsevier; 2006. p. 823–4.

    Google Scholar 

  25. McCarthy LE, Borison HL. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat Rep. 1984;68:401–4.

    PubMed CAS  Google Scholar 

  26. Lewis T. Pain. New York: Macmillan; 1942. p. 192.

  27. Troncon LE, Thompson DG, Ahluwalia NK, et al. Relations between upper abdominal symptoms and gastric distension abnormalities in dysmotility like functional dyspepsia and after vagotomy. Gut. 1995;37:17–22.

    Article PubMed CAS  Google Scholar 

  28. Miller AD, Nonaka S, Jakus J. Brain areas essential or non-essential for emesis. Brain Res. 1994;647:255–64.

    Article PubMed CAS  Google Scholar 

  29. Ahn AH, Brennan KC. Unanswered questions in headache: how does a migraine attack stop? Headache. 2012;52:186–7.

    Article PubMed  Google Scholar 

  30. Shapiro RE. How do migraine attacks stop? Headache. 2012;52:191–2.

    Article PubMed  Google Scholar 

  31. Vingen JV, Sand T, Stovner LJ. Sensitivity to various stimuli in primary headaches: a questionnaire study. Headache. 1999;39:552–8.

    Article PubMed CAS  Google Scholar 

  32. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.

    Article PubMed CAS  Google Scholar 

  33. Wober C, Brannath W, Schmidt K, et al. Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia. 2007;27:304–14.

    Article PubMed CAS  Google Scholar 

  34. Aurora SK, Kori SH, Barrodale P, et al. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache. 2006;46:57–63.

    Article PubMed  Google Scholar 

  35. Aurora S, Kori S, Barrodale P, Nelsen A, et al. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache. 2007;47:1443–6.

    Article PubMed  Google Scholar 

  36. • Aurora SK, Papapetropoulos S, Kori SH, et al. Gastric stasis in migraineurs: Etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33:408–15.A review on the physiologic link between migraine and autonomic dysfunction, specifically gastric stasis.

    Article PubMed  Google Scholar 

  37. Volans GN. Absorption of effervescent aspirin during migraine. Br Med J. 1974;4:265–8.

    Article PubMed CAS  Google Scholar 

  38. Hasler WL, Wilson LA, Parkman HP, et al. Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting. Neurogastroenterol Motil. 2013 Feb 17 [Epub ahead of print].

  39. Eadie MJ. An 18th century understanding of migraine - Samuel Tissot (1728–1797). J Clin Neurosci. 2003;10:414–9.

    Article PubMed CAS  Google Scholar 

  40. Parkman HP, Yates K, Hasler WL. et al; National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Clinical Research Consortium. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101–15.

    Article PubMed  Google Scholar 

  41. Maniyar FH, Sprenger T, Monteith T, et al. Investigating the premonitory phase of migraine with H215O PET. Cephalalgia. 2013;33(8 Suppl):12.

    Google Scholar 

  42. Rinaman L, Card JP, Schwaber JS, Miselis RR. Ultrastructural demonstration of a gastric monosynaptic vagal circuit in the nucleus of the solitary tract in rat. J Neurosci. 1989;9:1985–96.

    PubMed CAS  Google Scholar 

  43. Zhang W, Segura BJ, Lin TR, et al. Intercellular calcium waves in cultured enteric glia from neonatal guinea pig. Glia. 2003;42:252–62.

    Article PubMed  Google Scholar 

  44. Brennan KC, Bates EA, Shapiro RE, et al. Casein kinase Iδ mutations in familial migraine and advanced sleep phase. Sci Transl Med. 2013;5:(183)ra56.

  45. Lenaerts ME, Oommen KJ, Couch JR, et al. Can vagus nerve stimulation help migraine? Cephalalgia. 2008;28:392–5.

    Article PubMed CAS  Google Scholar 

  46. Holtmann G, Goebell H, Jockenhoevel F, et al. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998;42:501–6.

    Article PubMed CAS  Google Scholar 

  47. Zhang X, Cao B, Yan N, et al. Vagus nerve stimulation modulates visceral pain-related affective memory. Behav Brain Res. 2013;236:8–15.

    Article PubMed  Google Scholar 

  48. Chen SL, Wu XY, Cao ZJ, et al. Subdiaphragmatic vagal afferent nerves modulate visceral pain. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1441–9.

    Article PubMed CAS  Google Scholar 

  49. Sadler RM, Purdy RA, Sahey S. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia. 2002;22:482–4.

    Article PubMed CAS  Google Scholar 

  50. Hord ED, Evans MS, Mueed S, et al. The effect of vagus nerve stimulation on migraines. J Pain. 2003;4:530–4.

    Article PubMed  Google Scholar 

  51. Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia. 2005;25:82–6.

    Article PubMed CAS  Google Scholar 

  52. Cecchini AP, Mea E, Tullo V, et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: Preliminary data. Neurol Sci. 2009;30 Suppl 1:S101–4.

    Article PubMed  Google Scholar 

  53. Goadsby, et al. Non-invasive vagus nerve stimulation (nVNS) for acute treatment of migraine: an open-label pilot study, presented at the 2013 AAN Meeting, San Diego, CA, 20 March 2013.

  54. Randich A, Gebhart GF. Vagal afferent modulation of nociception. Brain Res Brain Res Rev. 1992;17:77–99.

    Article PubMed CAS  Google Scholar 

  55. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine attacks. Ann Neurol. 1990;28:183–7.

    Article PubMed CAS  Google Scholar 

  56. Lassen LH, Haderslev PA, Jacobsen VB, et al. CGRP may play a causative role in migraine. Cephalalgia. 2002;22:54–61.

    Article PubMed CAS  Google Scholar 

  57. Ho AP, Dahlof CG, Silberstein SD, et al. Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia. 2010;30:1443–57.

    Article PubMed  Google Scholar 

  58. Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine: Current understanding and state of development. Headache. 2013, in press.

  59. Rowe JW, Shelton RL, Helderman JH. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979;16:729–35.

    Article PubMed CAS  Google Scholar 

  60. Faull CM, Rooke P, Baylis PH. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man. Clin Endocrinol (Oxf). 1991;35:423–30.

    Article PubMed CAS  Google Scholar 

  61. Gupta VK. A clinical review of the adaptive role of vasopressin in migraine. Cephalalgia. 1997;17:561–9.

    Article PubMed CAS  Google Scholar 

  62. Berkenbosch F, De Goeij DC, Tilders FJ. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Endocrinology. 1989;125:28–34.

    Article PubMed CAS  Google Scholar 

  63. Gupta VK. Cyclic vomiting syndrome: anticipatory stress response in migraine? Headache. 2004;44:106–7.

    Article PubMed CAS  Google Scholar 

  64. Raskind MA, Courtney N, Murburg MM, et al. Antipsychotic drugs and plasma vasopressin in normal and acute schizophrenic patients. Biol Psychiatry. 1987;22:453–62.

    Article PubMed CAS  Google Scholar 

  65. Porth CJ, Bamarah VS, Tristani FE, et al. The Valsalva maneuver: mechanisms and clinical implications. Heart Lung. 1984;13:507–18.

    PubMed CAS  Google Scholar 

  66. Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: evidence for peripheral sensitization. Lancet Neurol. 2009;8:679–90.

    Article PubMed  Google Scholar 

  67. Wolff HG Headache and other head pain. 2nd edn. Oxford: Oxford University Press; 1963.

  68. Iversen HK, Nielsen TH, Olesen J, et al. Arterial responses during migraine headache. Lancet. 1990;336:837–9.

    Article PubMed CAS  Google Scholar 

  69. Wienecke T, Olesen J, Ashina M. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2010;30:179–90.

    PubMed CAS  Google Scholar 

  70. Blau JN, Dexter SL. The site of pain origin during migraine attacks. Cephalalgia. 1981;1:143–7.

    Article PubMed CAS  Google Scholar 

  71. Drummond PD, Lance JW. Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol. 1983;13:32–7.

    Article PubMed CAS  Google Scholar 

  72. Lipton SA. Prevention of classic migraine headache by digital massage of the superficial temporal arteries during visual aura. Ann Neurol. 1986;19:515–6.

    Article PubMed CAS  Google Scholar 

  73. Vijayan N. Head band for migraine headache relief. Headache. 1993;33:40–2.

    Article PubMed CAS  Google Scholar 

  74. Hmaidan Y, Cianchetti C. Effectiveness of a prolonged compression of scalp arteries on migraine attacks. J Neurol. 2006;253:811–12.

    Article PubMed  Google Scholar 

  75. • Cianchetti C. The role of neurovascular scalp structures in migraine. Cephalalgia. 2012;32:778–84.A review suggesting the role of scalp neurovascular structures in the production of migraine pain in at least part of the migraine patient population.

    Article PubMed  Google Scholar 

  76. Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–7.

    Article PubMed  Google Scholar 

  77. Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 2013;12:454–61.

    Article PubMed  Google Scholar 

  78. Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008;28:226–36.

    Article PubMed CAS  Google Scholar 

  79. Dodick DW. Examining the essence of migraine – is it the blood vessel or the brain? A debate Headache. 2008;48:661–7.

    Article  Google Scholar 

  80. Hansen JM, Sitarz J, Birk S, et al. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia. 2006;26:992–1003.

    Article PubMed CAS  Google Scholar 

  81. Amin FM, Asghar MS, Ravneberg JW, et al. The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteers. Cephalalgia. 2013 Apr 15 [Epub ahead of print].

  82. Tissot, S-A, Traité des nerfs et de leurs maladies, 1778, IX p.90–173. A Lausanne: Chex François Grasset & Comp.

  83. Ellis GL, Delaney J, DeHart DA, et al. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993;22:191–5.

    Article PubMed CAS  Google Scholar 

  84. Derry S, Moore RA, McQuay HJ. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headache in adults. Cochrane Database Syst Rev. 2010;11, CD008040.

    PubMed  Google Scholar 

  85. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2012;2, CD008783.

    PubMed  Google Scholar 

  86. Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without antiemetic for acute migraine headache in adults. Cochrane Database Syst Rev. 2010;10, CD008039.

    PubMed  Google Scholar 

  87. Yin J, Abell TD, McCallum RW, et al. Gastric neuromodulation with Enterra system for nausea and vomiting in patients with gastroparesis. Neuromodulation. 2012;15:224–31.

    Article PubMed  Google Scholar 

  88. Abell TL, Johnson WD, Kedar A, Runnels JM, Thompson J, Weeks ES, et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc. 2011;74:496–503.

    Article PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank the following for their insightful comments and contributions to our survey questions: Dr Allan Purdy (Dalhousie University, Nova Scotia); Dr.David Kudrow (California Medical Clinic for Headache); Dr Emeran Mayer (UCLA); Dr Massimo Leone (Istituto Nazionale Neurologico C. Besta, Milano, Italy); Dr Peter Goadsby (UCSF); and Dr K Ravishankar (Jaslok Hospital and Research Centre and Lilavati Hospital and Research Centre, Mumbai, India).

Compliance with Ethics Guidelines

Conflict of Interest

Nu Cindy Chai reported no potential conflicts of interest relevant to this article.

Dr Robert E. Shapiro reported no potential conflicts of interest relevant to this article.

Dr Alan M. Rapoport reported no potential conflicts of interest relevant to this article.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Neurology, Johns Hopkins University School of Medicine, Sheikh Zayed Tower, Room 6005, 1800 Orleans Street, Baltimore, MD, USA

    Nu Cindy Chai

  2. Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT, USA

    Robert E. Shapiro

  3. Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Alan M. Rapoport

Authors
  1. Nu Cindy Chai
  2. Robert E. Shapiro
  3. Alan M. Rapoport

Corresponding author

Correspondence toNu Cindy Chai.

Additional information

This article is part of the Topical Collection onMigraine

Rights and permissions

About this article

Associated Content

Part of a collection:

Topical Collection on Migraine

Access this article

Subscribe and save

Springer+ Basic
¥17,985 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Japan)

Instant access to the full article PDF.

Advertisement


[8]ページ先頭

©2009-2025 Movatter.jp